MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
A summarized report of the Virtual MedTech

A Summarized Report of the Virtual MedTech EU MDR Exchange Conference

Session summaries from EUMDR exchange conference 2021...
Using digital enhancements to maximize engagement

Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?

Best practices to implement digital enhancements and measure effectiveness...
UX design for scientific writing

Future of Scientific Writing and Journal Articles with UX Design

Take a look at some ideas and examples on how user experience design can be...
ISMPP full report image

17th Virtual Annual Meeting of ISMPP: A Summarized Report

Session summaries from the latest ISMPP conference on trust and equity in science, digital transformation...
Pexels Anna Shvets

How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead

The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...

Learn more ABOUT our company.